MedTrace Logo

Testing Radical Prostatectomy in Chinese Men With Prostate Cancer and oligoMetastases to the Bone

NCT03988686 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2019-06-17

No results posted yet for this study

Summary

This study is to examine whether radical prostatectomy can impact survival and quality-of-life in men with oligo-metastatic prostate cancer.

Conditions

  • Prostate Cancer Metastatic

Interventions

PROCEDURE

Radical prostatectomy plus standard care

To add radical prostatectomy on the basis of current standard of care for those with oligometastatic prostate cancer

DRUG

Standard of care for metastatic prostate cancer

androgen deprivation therapy with or without other systemic therapies based on current guidelines for metastatic prostate cancer

Sponsors & Collaborators

  • University College, London

    collaborator OTHER

  • Fudan University

    lead OTHER

Principal Investigators

  • Jian-Ming Guo, MD, PhD · Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2021-03-31
Completion
2022-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03988686 on ClinicalTrials.gov